U.S. Senator Bill Cassidy, M.D., Chairman of the Senate Health, Education, Labor, and Pensions Committee, announced on Mar. 25 that he is expanding his investigation into the American Academy of Pediatrics and the Endocrine Society regarding their influence on policies about gender transition surgeries for minors.
The issue centers on concerns about whether leading medical organizations are encouraging changes to guidelines that could allow irreversible procedures for children. The investigation has implications for families and health policy nationwide due to the committee’s broad legislative reach over public health matters.
“These organizations are defying science and promoting irreversible gender transition surgeries for children,” said Dr. Cassidy. “American families deserve to know why some of the leading medical organizations in the world prioritize politics over their children.”
Cassidy said he had previously requested assistance from the U.S. Department of Health and Human Services to review communications between former administration officials, WPATH (World Professional Association for Transgender Health), and other medical groups. He also referenced recent actions including joining HHS Secretary Robert F. Kennedy Jr. at an event announcing a new policy aimed at preventing federal funds from being used for such procedures in minors, as well as introducing legislation titled No Subsidies for Gender Transition Procedures Act targeting Medicaid, Medicare, CHIP, and Affordable Care Act funding.
The Senate Health, Education, Labor, and Pensions Committee works to legislate on public health issues with a focus on protecting health and supporting worker rights according to its official website. In the current Congress, Cassidy serves as chair of this committee according to its official website. The committee influences federal regulations affecting health care across the United States according to its official website, provides oversight of relevant laws and agencies according to its official website, and oversees agencies such as the Food and Drug Administration (FDA) and National Institutes of Health (NIH) according to its official website.
The outcome of this investigation may affect future federal policies regarding pediatric gender transition procedures.
